BUI Publications 2014

Hashim H, Abrams P. Transurethral Resection of the Prostate for Benign Prostatic Obstruction: Will It Remain the Gold Standard? Eur Urol. 2014 Dec 23.

Abrams P, Cardozo L, Wein A. Fourth international consultation on incontinence-research society 2013. Neurourol Urodyn. 2014 Jun;33(5):571-2.

Bright E, Cotterill N, Drake M, Abrams P. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary. Eur Urol. 2014 Aug;66(2):294-300.

Subak LL, Goode PS, Brubaker L, Kusek JW, Schembri M, Lukacz ES, Kraus SR, Chai TC, Norton P, Tennstedt SL; Urinary Incontinence Treatment Network. Urinary incontinence management costs are reduced following Burch or sling surgery for stress incontinence. Am J Obstet Gynecol. 2014 Aug;211(2):171.e1-7.

Zyczynski HM, Sirls LT, Greer WJ, Rahn DD, Casiano E, Norton P, Kim HY, Brubaker L; Urinary Incontinence Treatment Network. Findings of universal cystoscopy at incontinence surgery and their sequelae. Am J Obstet Gynecol. 2014  May;210(5):480.e1-8.

Warren K, Burden H, Abrams P. Lower urinary tract symptom: still too much focus on the prostate? Curr Opin Urol. 2014 Jan;24(1):3-9.

Romancik M, Pandian S, Drake MJ. Tamsulosin/solifenacin fixed-dose combination tablet for the treatment of male lower urinary tract symptoms. Drugs Today (Barc). 2014 Dec;50(12):803-11.

Thiruchelvam N, Drake MJ, Venn S, Morley R; On behalf of the BAUS section of Female, Neurological and Urodynamics. A 2014 snapshot audit of the role of urodynamics in the UK for benign prostatic enlargement surgery. Neurourol Urodyn. 2014 Nov 28.

Bijos DA, Drake MJ, Vahabi B. Anoctamin-1 in the juvenile rat urinary bladder. PLoS One. 2014 Sep 2;9(9)

Drake MJ, Williams J, Bijos DA. Voiding dysfunction due to detrusor underactivity: an overview. Nat Rev Urol. 2014 Aug;11(8):454-64

Drake MJ. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013. Neurourol Urodyn. 2014 Jun;33(5):622-4.

Chapple CR, Drake MJ, Van Kerrebroeck P, Cardozo L, Drogendijk T, Klaver M, Van Charldorp K, Hakimi Z, Compion G. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary  tract symptoms. BJU Int. 2014 May;113(5):696-703

Hofmeester I, Kollen BJ, Steffens MG, Bosch JL, Drake MJ, Weiss JP, Blanker MH. Impact of the International Continence Society (ICS) report on the standardisation of terminology in nocturia on the quality of reports on nocturia  and nocturnal polyuria: a systematic review. BJU Int. 2014 Mar 31.

Hagen RM, Adamo P, Karamat S, Oxley J, Aning JJ, Gillatt D, Persad R, Ladomery MR, Rhodes A. Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence. Am J Clin Pathol. 2014 Oct;142(4):533-40

Goonewardene SS, Persad R, Young A, Makar A. Re: Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry:J Urol 2014; 191: 964-970. J Urol. 2014 Dec;192(6):1889-90

Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, Turner EL, Mason MD, Metcalfe C, Peters TJ, Martin RM, Neal DE, Hamdy FC; ProtecT study group. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer:study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 2014 Sep;15(10):1109-18.

Goonewardene SS, Persad R, Nanton V, Young A, Makar A. Prostate cancer survivorship: lifestyle changes, much needed! World J Urol. 2014 Jul 10.

Bach C, Pisipati S, Daneshwar D, Wright M, Rowe E, Gillatt D, Persad R,Koupparis A. The status of surgery in the management of high-risk prostate cancer. Nat Rev Urol. 2014 Jun;11(6):342-51.

Goonewardene SS, Persad R, Nanton V, Young A, Makar A. Re: Anna Bill-Axelson, Hans Garmo, Lars Holmberg, et al. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol 2013;64:920-8. Eur Urol. 2014 Jun;65(6):e104-5.

Goonewardene SS, Rowe EW. Radical robotic-assisted laparoscopic prostatectomy: a daycase procedure. J Laparoendosc Adv Surg Tech A. 2014 Nov;24(11):804-5.

Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, Turner EL, Mason MD, Metcalfe C, Peters TJ, Martin RM, Neal DE, Hamdy FC; ProtecT study group. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 2014 Sep;15(10):1109-18.

Aning JJ, Thurairaja R, Gillatt DA, Koupparis AJ, Rowe EW, Oxley J.Pathological analysis of lymph nodes in anterior prostatic fat excised at robot-assisted radical prostatectomy. J Clin Pathol. 2014 Sep;67(9):787-91.

Cundell DS, Rowe E, Oxley J. Intraductal spread of prostate cancer into the seminal vesicles. Histopathology. 2014 Jun;64(7):1039-41

Fowler S, Godfrey H, Fader M, Timoney AG, Long A. Living with a long-term, indwelling urinary catheter: catheter users' experience. J Wound Ostomy Continence Nurs. 2014 Nov-Dec;41(6):597-603.

Long A, Edwards J, Thompson R, Lewis DA, Timoney AG. A clinical evaluation of a sensor to detect blockage due to crystalline biofilm formation on indwelling urinary catheters. BJU Int. 2014 Aug;114(2):278-85

Vannahme M, Mathur S, Davenport K, Timoney AG, Keeley FX Jr. The management of secondary pelvi-ureteric junction obstruction - a comparison of pyeloplasty and endopyelotomy. BJU Int. 2014 Jan;113(1):108-12.

Keeley FX Jr. Public reporting of individual surgeons' outcomes in the UK. Can J Urol. 2014 Oct;21(5):7429.

Keeley FX Jr. Global CROES ureteroscopy registry demonstrates striking cooperation among endourologists. Eur Urol. 2014 Jul;66(1):110-1.

Keeley FX Jr. Stent placement under local: too painful to be practical? Can J Urol. 2014 Feb;21(1):7125. PubMed PMID: 24529013.

Dellis AE, Keeley FX Jr, Manolas V, Skolarikos AA. Role of α-blockers in the treatment of stent-related symptoms: a prospective randomized control study. Urology. 2014 Jan;83(1):56-61.

de la Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, Preminger G, Traxer O; CROES URS Study Group. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014 Feb;28(2):131-9.

Sanguedolce F, Millán-Rodriguez F, Santillana-Altimira JM, Fantova-Alonso A, Sánchez-Martín FM, Angerri-Feu O, Lopez Martinez JM, Keeley FX, Joshi HB, Villavicencio-Mávrich H. The Spanish linguistic validation of the ureteral stent  symptom questionnaire. J Endourol. 2014 Feb;28(2):237-42

Hounsome LS, Verne J, McGrath JS, Gillatt DA. Trends in Operative Caseload and Mortality Rates after Radical Cystectomy for Bladder Cancer in England for 1998-2010. Eur Urol. 2014 Dec 16.

Mavrou A, Brakspear K, Hamdollah-Zadeh M, Damodaran G, Babaei-Jadidi R, Oxley J, Gillatt DA, Ladomery MR, Harper SJ, Bates DO, Oltean S. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene. 2014 Nov 10.

Tolchard S, Angell J, Pyke M, Lewis S, Dodds N, Darweish A, White P, Gillatt D. Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy. BJU Int. 2014 Aug 11.

Salji M, Jones R, Paul J, Birrell F, Dixon-Hughes J, Hutchison C, Johansen TE, Greene D, Parr N, Leung HY; Cryotherapy in Prostate Cancer (CROP) study team. Feasibility study of a randomised controlled trial to compare (deferred) androgen deprivation therapy and cryotherapy in men with localised radiation-recurrent prostate cancer. Br J Cancer. 2014 Jul 29;111(3):424-9.

Moradi M, Mahdavi SS, Nir G, Mohareri O, Koupparis A, Gagnon LO, Fazli L, Casey RG, Ischia J, Jones EC, Goldenberg SL, Salcudean SE. Multiparametric 3D in  vivo ultrasound vibroelastography imaging of prostate cancer: Preliminary results. Med Phys. 2014 Jul;41(7)

Turner EL, Metcalfe C, Donovan JL, Noble S, Sterne JA, Lane JA, Avery KN, Down L, Walsh E, Davis M, Ben-Shlomo Y, Oliver SE, Evans S, Brindle P, Williams NJ, Hughes LJ, Hill EM, Davies C, Ng SY, Neal DE, Hamdy FC, Martin RM; CAP trial group. Design and preliminary recruitment results of the Cluster randomised trial of PSA testing for Prostate cancer (CAP). Br J Cancer. 2014 Jun 10;110(12):2829-36

Warren KS, Oxley J, Koupparis A. Pure malignant rhabdoid tumour of the bladder. Can Urol Assoc J. 2014 Mar;8(3-4):E260-2.